New launches, chronic portfolio to maintain growth for Zydus Lifesciences ...Middle East

Business Standard - Economy
New launches, chronic portfolio to maintain growth for Zydus Lifesciences
Strong domestic formulations, chronic therapies, new US launches and a complex-product pipeline have supported the rally, though valuations now stand above historical averages

Hence then, the article about new launches chronic portfolio to maintain growth for zydus lifesciences was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New launches, chronic portfolio to maintain growth for Zydus Lifesciences )

Apple Storegoogle play

Last updated :

Also on site :